First-in-Class Small Molecule to Inhibit CYP11A1 and Steroid Hormone Biosynthesis.

Overview of attention for article published in Molecular Cancer Therapeutics, September 2022

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 3,475 followers.

First-in-Class Small Molecule to Inhibit CYP11A1 and Steroid Hormone Biosynthesis. https://t.co/33C3FtL6LE https://t.co/c0zZJ8yFKc

First-in-Class Small Molecule to Inhibit CYP11A1 And Steroid Hormone Biosynthesis #HelsinkiHealth #tutkimus #tiede https://t.co/LLKVBi9g3N

New article: First-in-Class Small Molecule to Inhibit CYP11A1 And Steroid Hormone Biosynthesis https://t.co/8HgSt9kpTC #prostatecancer #oncology https://t.co/ZEwF1WNmQb

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.